Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

ACEA Pharma

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
For Profit

ACEA Pharma is a clinical-stage pharmaceutical company developing treatments for cancer, autoimmune disease, and COVID-19.

ACEA Pharma on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

ACEA Pharma was acquired by Winfield Engineering in 2026 for $1B.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0

About ACEA Pharma

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Company Info

Operating status
Active
Company type
For Profit
Org types
company
News articles
5
Exit date
May 4, 2026

Signals & Scores

Heat score
Low
Growth score
High
Trend (7d)
0.3
Trend (30d)
-7.4
Trend (90d)
5.3

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to ACEA Pharma

Loading news…

FAQs about ACEA Pharma

People who checked this page also checked these

Browse the full Acquirezy directory.
ACEA Pharma — Company Profile